Liu, Qiang
Salanti, Georgia
De Crescenzo, Franco
Ostinelli, Edoardo Giuseppe
Li, Zhenpeng
Tomlinson, Anneka
Cipriani, Andrea
Efthimiou, Orestis
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (179158, 180083)
National Institute for Health Research (RP-2017-08-ST2-006)
Article History
Received: 20 January 2022
Accepted: 3 May 2022
First Online: 16 May 2022
Declarations
:
: Our research did not involve the use of human tissue samples. All methods were performed in accordance with the relevant guidelines and regulations. Individual patient consent is not required for this use of anonymized, routine data. The project supporting this research was independently peer-reviewed by the QResearch Scientific Committee and was approved on 1 July 2019. The ethics approval reference is 18/EM/0400. The research approval is available at: ExternalRef removed [Accessed on 16 December 2021].
: Individual patient consent is not required for this use of anonymized, routine data.
: Franco De Crescenzo is supported by the NIHR Research Professorship to Professor Andrea Cipriani (grant RP-2017-08-ST2–006) and by the NIHR Oxford Health Biomedical Research Centre (grant BRC-1215-20005). Edoardo G. Ostinelli has received research and consultancy fees from Angelini Pharma. Andrea Cipriani has received research and consultancy fees from INCiPiT (Italian Network for Paediatric Trials), CARIPLO Foundation and Angelini Pharma, outside the submitted work. The other authors declare no conflicts of interest.